Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis.
about
Paying attention to smell: cholinergic signaling in the olfactory bulbThe Cooperative Health Research in South Tyrol (CHRIS) study: rationale, objectives, and preliminary resultsNon-Linear EMG Parameters for Differential and Early Diagnostics of Parkinson's Disease.Olfactory Impairment in Parkinson's Disease Studied with Diffusion Tensor and Magnetization Transfer Imaging.Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's diseaseThe range and nature of non-motor symptoms in drug-naive Parkinson's disease patients: a state-of-the-art systematic reviewOlfactory dysfunction in Parkinson's disease: Benefits of quantitative odorant examination.Carbonic anhydrase I, II, and VI, blood plasma, erythrocyte and saliva zinc and copper increase after repetitive transcranial magnetic stimulation.Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease.Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients.Diagnostic value of the impairment of olfaction in Parkinson's diseaseLewy bodies and olfactory dysfunction in old ageOlfactory deficits in mice overexpressing human wildtype alpha-synuclein.Olfactory loss in Parkinson's disease.Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease.Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.Abnormal Olfaction in Parkinson's Disease Is Related to Faster Disease Progression.Suprathreshold odor intensity perception in early-stage Parkinson's disease.Olfaction in Parkinson's disease and related disorders.Target Selection Recommendations Based on Impact of Deep Brain Stimulation Surgeries on Nonmotor Symptoms of Parkinson's DiseasePediatric respiratory and systemic effects of chronic air pollution exposure: nose, lung, heart, and brain pathology.Neuropsychological correlates of manganese exposure: a meta-analysis.Olfactory assays for mouse models of neurodegenerative disease.Role of homocysteine in the treatment of Parkinson's disease.Variability of EMG patterns: a potential neurophysiological marker of Parkinson's disease?Effects of bilateral deep brain stimulation of the subthalamic nucleus on olfactory function in Parkinson's disease patients.Recognition and management of Parkinson's disease during the premotor (prodromal) phase.Olfactory dysfunction as a diagnostic marker for Parkinson's disease.Olfaction as a biomarker in Parkinson's disease.Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.Olfactory dysfunctions in neurodegenerative disorders.Parkinson disease and sleep: sleep-wake changes in the premotor stage of Parkinson disease; impaired olfaction and other prodromal features.Olfactory bulb involvement in neurodegenerative diseases.Odor identification in frontotemporal lobar degeneration subtypes.The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.Accelerometer-based quantitative analysis of axial nocturnal movements differentiates patients with Parkinson's disease, but not high-risk individuals, from controls.DNA damage in nasal and brain tissues of canines exposed to air pollutants is associated with evidence of chronic brain inflammation and neurodegeneration.Hyposmia and executive dysfunction as predictors of future Parkinson's disease: a prospective study.Prodromal non-motor symptoms of Parkinson's disease.Comparison of Olfactory Identification Patterns among Parkinson's Disease Patients from Different Countries.
P2860
Q27008213-8C6E477D-E2B3-4B4A-8550-C5EE833FC158Q28607743-B94CD80D-7618-4527-85EC-A668A88DB0C0Q30449049-CBF22F13-3620-49DD-8935-ED2930D96A10Q33708913-C1EE0FBF-8919-4B04-B5AD-E722E39F82BEQ33882719-079CF06C-1CD7-49E6-939B-C56A13BC2767Q33917211-FF11F11C-F5DE-43B8-AFDD-11C9C550989BQ34041872-EDD33AAA-AF79-4BEE-ACE3-64E815FB2585Q34083371-D514C5E9-87DE-439F-91D8-11366B2958B7Q34235667-704CDCAF-8BF2-4437-BF56-0BB5EA76BC97Q34470963-D75F5DD8-0047-4452-B95E-0AD010A9C1D4Q34734246-23F07B6A-E55A-4BBC-9FA6-B6197112BB09Q34776843-7B4A60A7-9D78-4FDE-B5A3-B0B5EC4CBB29Q35026044-6FEF54C1-FE98-4E34-977C-3B63DDF3C893Q35028848-A7EA3F42-1738-429B-9AC3-603E3086862BQ35201409-655CB880-2780-43DA-8E87-0850A3517849Q35614156-79C03C21-7072-43B6-9ED7-52708CB4F359Q35744871-38D11A15-BC28-4BD1-A439-A69D9A87D0B0Q35878660-48AE179D-A4C8-4147-B56A-007E364F1BA8Q36193915-FBFD48EF-0CB7-43A5-BDCC-76FD09033341Q36701655-688B921B-D8FD-4916-9860-5A383284834EQ36746486-A2C8B7B4-9B09-44A0-91A5-17E501EE11EDQ36761838-DB798EFE-73B4-4C0D-9D1D-C3940563A768Q36787949-84F56A8D-47FB-4FC8-A844-28B2F5E74479Q37174063-731850A7-5392-4D8B-B34C-8BBA73CEA599Q37186446-1213F8C8-5FCE-430F-BA78-9271ECD0CFF5Q37466992-C57EEEA7-9B0D-4E19-97E8-A1E20F34E7D8Q37507968-5364FB35-3244-4474-A5B7-9BB175822649Q37641997-F201D94D-CC0C-49F5-9E62-346F840D29B0Q37800097-021BE617-6C95-4900-A6B9-FED2B2E8231FQ37946305-AB8CA78C-A581-4CCA-AE77-94FC9BFB85D2Q38016791-52809199-CC43-4C54-883F-979B21B2F43FQ38123748-F4FF9BE3-8406-4E1B-AD9A-F2D5204761BAQ38189727-B1755B7D-88E1-4F5F-AE33-8228CA302FBBQ38428232-10B5F699-F6E5-416F-B97B-3B0E299B9B15Q39052041-4680706E-69B9-451A-B7B5-608A9F3A58F5Q39202020-0515A85F-CB64-4D1B-9A3D-6FDAC7359BFAQ39672283-40CC9E44-FBB9-4DDA-88E8-7B6C78AA9068Q39989016-0670D949-99BB-4481-A1ED-E9FD472B59CDQ40247459-55E11B38-59D7-40B5-8A24-F083A9B8903CQ40381622-942D2AC7-F1E1-4E45-A680-433B7C8FF742
P2860
Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Loss of olfaction in de novo a ...... lications for early diagnosis.
@ast
Loss of olfaction in de novo a ...... lications for early diagnosis.
@en
type
label
Loss of olfaction in de novo a ...... lications for early diagnosis.
@ast
Loss of olfaction in de novo a ...... lications for early diagnosis.
@en
prefLabel
Loss of olfaction in de novo a ...... lications for early diagnosis.
@ast
Loss of olfaction in de novo a ...... lications for early diagnosis.
@en
P2093
P2860
P1433
P1476
Loss of olfaction in de novo a ...... lications for early diagnosis.
@en
P2093
Berendse HW
Bergmans P
Drukarch B
Tissingh G
Wolters EC
P2860
P356
10.1002/1531-8257(200101)16:1<41::AID-MDS1017>3.0.CO;2-M
P407
P577
2001-01-01T00:00:00Z